Constrictive pericarditis after SARS-CoV-2 vaccination: A case report.
Int J Infect Dis 2022 Mar; 116:238-240.

Abstract

Coronavirus disease 2019 (COVID-19) and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are associated with cardiovascular complications. Here, we report a case of right-sided heart failure caused by constrictive pericarditis that developed after the administration of messenger ribonucleic acid (mRNA) vaccine against SARS-CoV-2. A 70-year-old woman presented with body weight gain, peripheral edema, and dyspnea on effort, which developed over a period of 1 week after the second dose of vaccine. The jugular venous pressure was high with a prominent y descent (Friedreich's sign) and paradoxical increase on inspiration (Kussmaul's sign). The results of IgM and IgG testing specific to SARS-CoV-2 spike and nucleocapsid proteins indicated the presence of mRNA vaccine-induced antibody and were not suggestive of COVID-19 infection. Echocardiography showed pericardial thickening and septal bounce of the interventricular septum. Computed tomography (CT) also showed pericardial thickening compared with the results of the previous CT scan performed 4 months earlier. A diagnosis of right-sided heart failure due to constrictive pericarditis was confirmed on the basis of pressure analysis during cardiac catheterization.

Authors+Show Affiliations

Nakanishi YDepartment of Cardiology, Matsushita Memorial Hospital, Moriguchi, Osaka, Japan.
Honda SDepartment of Cardiology, Matsushita Memorial Hospital, Moriguchi, Osaka, Japan. Electronic address: honda.sakiko@jp.panasonic.com.
Yamano MDepartment of Cardiology, Matsushita Memorial Hospital, Moriguchi, Osaka, Japan.
Kawasaki TDepartment of Cardiology, Matsushita Memorial Hospital, Moriguchi, Osaka, Japan.
Yoshioka KYoshioka Diabetes Clinic, Moriguchi, Osaka, Japan.

Pub Type(s)

Case Reports

Language

eng

PubMed ID

35063679